SCHEMBL8976361

SCHEMBL8976361

C[C@H](COc1ccc(CC(=O)O)cc1)NC[C@H](O)c1cccc(Cl)c1

nearest known ligand 0.71

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ADRB3 P13945 16/20 0.71
▸ ADRB2 P07550 14/20 0.71
▸ ADRB1 P08588 10/20 0.71
▸ CYP2D6 P10635 2/20 0.71
▸ ADRA1D P25100 1/20 0.71
▸ ADRA1A P35348 1/20 0.71
▸ ADRA1B P35368 1/20 0.71
▸ CYP1A2 P05177 1/20 0.71
▸ CYP2C9 P11712 1/20 0.71
▸ CYP2C19 P33261 1/20 0.71
▸ GLA P06280 1/20 0.64
▸ CYP3A4 P08684 1/20 0.63
▸ HIF1A Q16665 1/20 0.63
▸ SLC2A1 P11166 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8976358 1.00 ADRB3 (0.71) ADRB3ADRB2ADRB1CYP2D6ADRA1D
SCHEMBL8976357 0.91 ADRB3 (0.68) ADRB3ADRB2ADRB1CYP2D6ADRA1D
SCHEMBL8402067 0.91 ADRB3 (0.72) ADRB3ADRB2ADRB1CYP2D6ADRA1D
SCHEMBL8402448 0.91 ADRB3 (0.72) ADRB3ADRB2ADRB1CYP2D6ADRA1D
SCHEMBL8402209 0.88 ADRB3 (0.69) ADRB3ADRB2ADRB1CYP2D6ADRA1D
Fumaric Acid SCHEMBL8406987 0.88 ADRB3 (0.65) ADRB3ADRB2ADRB1CYP2D6ADRA1D
Fumaric Acid SCHEMBL8406993 0.88 ADRB3 (0.65) ADRB3ADRB2ADRB1CYP2D6ADRA1D
Fumaric Acid SCHEMBL8911242 0.88 ADRB3 (0.65) ADRB3ADRB2ADRB1CYP2D6ADRA1D
Fumaric Acid SCHEMBL8406896 0.88 ADRB3 (0.65) ADRB3ADRB2ADRB1CYP2D6ADRA1D
SCHEMBL8402065 0.86 ADRB3 (0.70) ADRB3ADRB2ADRB1CYP2D6ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0706386-A1 USE OF PHENETHANOLAMINE DERIVATIVES IN THE TREATMENT OF GASTROINTESTINAL DISORDERS GLAXO GROUP LIMITED (GB) 1996-04-17 — — EP disclosed
WO-1995001170-A2 USE OF PHENETHANOLAMINE DERIVATIVES IN THE TREATMENT OF GASTROINTESTINAL DISORDERS GLAXO GROUP LIMITED (GB) 1995-01-12 — — WO disclosed
Send feedback